The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2015 Mar 27

PMID 25809477

Citations 18

Authors

Masayoshi Souri

Tsukasa Osaki

Akitada Ichinose

Affiliations

Soon will be listed here.

Abstract

Covalent cross-linking of fibrin chains is required for stable blood clot formation, which is catalyzed by coagulation factor XIII (FXIII), a proenzyme of plasma transglutaminase consisting of catalytic A (FXIII-A) and non-catalytic B subunits (FXIII-B). Herein, we demonstrate that FXIII-B accelerates fibrin cross-linking. Depletion of FXIII-B from normal plasma supplemented with a physiological level of recombinant FXIII-A resulted in delayed fibrin cross-linking, reduced incorporation of FXIII-A into fibrin clots, and impaired activation peptide cleavage by thrombin; the addition of recombinant FXIII-B restored normal fibrin cross-linking, FXIII-A incorporation into fibrin clots, and activation peptide cleavage by thrombin. Immunoprecipitation with an anti-fibrinogen antibody revealed an interaction between the FXIII heterotetramer and fibrinogen mediated by FXIII-B and not FXIII-A. FXIII-B probably binds the γ-chain of fibrinogen with its D-domain, which is near the fibrin polymerization pockets, and dissociates from fibrin during or after cross-linking between γ-chains. Thus, FXIII-B plays important roles in the formation of a ternary complex between proenzyme FXIII, prosubstrate fibrinogen, and activator thrombin. Accordingly, congenital or acquired FXIII-B deficiency may result in increased bleeding tendency through impaired fibrin stabilization due to decreased FXIII-A activation by thrombin and secondary FXIII-A deficiency arising from enhanced circulatory clearance.

Citing Articles

Hidden in plain sight: How helminths manage to thrive in host blood.

Dagenais M, Tritten L Front Parasitol. 2025; 2():1128299.

PMID: 39816845 PMC: 11732017. DOI: 10.3389/fpara.2023.1128299.

A case of autoimmune factor XIII deficiency due to clearance-accelerating and inhibitory anti-FXIII autoantibodies.

Tsunemine H, Souri M, Kumode W, Arima N, Ichinose A Int J Hematol. 2024; 121(2):257-264.

PMID: 39589696 DOI: 10.1007/s12185-024-03874-1.

Exploring the function of factor XIII free B subunit: Interactions with complement factors and a novel approach to identify potential binding partners.

Li B, Bechtler C, Jenny L, Ricklin D, Schroeder V Res Pract Thromb Haemost. 2022; 6(5):e12766.

PMID: 35873217 PMC: 9301527. DOI: 10.1002/rth2.12766.

Exploring Diverse Coagulation Factor XIII Subunit Expression Datasets: A Bioinformatic Analysis.

Jamil M, Singh S, El-Maarri O, Oldenburg J, Biswas A Int J Mol Sci. 2022; 23(9).

PMID: 35563115 PMC: 9099568. DOI: 10.3390/ijms23094725.

The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing.

Kleber C, Sablotzki A, Casu S, Olivieri M, Thoms K, Horter J Crit Care. 2022; 26(1):69.

PMID: 35331308 PMC: 8943792. DOI: 10.1186/s13054-022-03940-2.

References

Shevchenko A, Tomas H, Havlis J, Olsen J, Mann M . In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 2007; 1(6):2856-60. DOI: 10.1038/nprot.2006.468. View

Lorand L . Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Ann N Y Acad Sci. 2001; 936:291-311. DOI: 10.1111/j.1749-6632.2001.tb03516.x. View

Souri M, Koseki-Kuno S, Takeda N, Degen J, Ichinose A . Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice. Int J Hematol. 2008; 87(1):60-8. DOI: 10.1007/s12185-007-0005-z. View

Souri M, Kaetsu H, Ichinose A . Sushi domains in the B subunit of factor XIII responsible for oligomer assembly. Biochemistry. 2008; 47(33):8656-64. DOI: 10.1021/bi8006143. View

Iwata H, Kitano T, Umetsu K, Yuasa I, Yamazaki K, Kemkes-Matthes B . Distinct C-terminus of the B subunit of factor XIII in a population-associated major phenotype: the first case of complete allele-specific alternative splicing products in the coagulation and fibrinolytic systems. J Thromb Haemost. 2009; 7(7):1084-91. DOI: 10.1111/j.1538-7836.2009.03443.x. View

Ivaskevicius V, Biswas A, Loreth R, Schroeder V, Ohlenforst S, Rott H . Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency. Haemophilia. 2010; 16(4):675-82. DOI: 10.1111/j.1365-2516.2010.02207.x. View

Koseki S, Souri M, Koga S, Yamakawa M, Shichishima T, Maruyama Y . Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation. Blood. 2001; 97(9):2667-72. DOI: 10.1182/blood.v97.9.2667. View

Saha N, Aston C, Low P, Kamboh M . Racial and genetic determinants of plasma factor XIII activity. Genet Epidemiol. 2000; 19(4):440-55. DOI: 10.1002/1098-2272(200012)19:4<440::AID-GEPI14>3.0.CO;2-8. View

Pechik I, Madrazo J, Mosesson M, Hernandez I, Gilliland G, Medved L . Crystal structure of the complex between thrombin and the central "E" region of fibrin. Proc Natl Acad Sci U S A. 2004; 101(9):2718-23. PMC: 365687. DOI: 10.1073/pnas.0303440101. View

10.

Pizzo S, Taylor Jr L, Schwartz M, Hill R, McKee P . Subunit structure of fragment D from fibrinogen and cross-linked fibrin. J Biol Chem. 1973; 248(13):4584-90. View

11.

Curtis C, Brown K, Credo R, Domanik R, Gray A, Stenberg P . Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. Biochemistry. 1974; 13(18):3774-80. DOI: 10.1021/bi00715a024. View

12.

Laudano A, Doolittle R . Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci U S A. 1978; 75(7):3085-9. PMC: 392718. DOI: 10.1073/pnas.75.7.3085. View

13.

Blomback B, HESSEL B, Hogg D, Therkildsen L . A two-step fibrinogen--fibrin transition in blood coagulation. Nature. 1978; 275(5680):501-5. DOI: 10.1038/275501a0. View

14.

Credo R, Curtis C, Lorand L . Ca2+-related regulatory function of fibrinogen. Proc Natl Acad Sci U S A. 1978; 75(9):4234-7. PMC: 336086. DOI: 10.1073/pnas.75.9.4234. View

15.

Olexa S, Budzynski A . Evidence for four different polymerization sites involved in human fibrin formation. Proc Natl Acad Sci U S A. 1980; 77(3):1374-8. PMC: 348497. DOI: 10.1073/pnas.77.3.1374. View

16.

Greenberg C, Shuman M . The zymogen forms of blood coagulation factor XIII bind specifically to fibrinogen. J Biol Chem. 1982; 257(11):6096-101. View

17.

Janus T, Lewis S, Lorand L, Shafer J . Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen. Biochemistry. 1983; 22(26):6269-72. DOI: 10.1021/bi00295a035. View

18.

Greenberg C, Miraglia C . The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation. Blood. 1985; 66(2):466-9. View

19.

Greenberg C, Dobson J, Miraglia C . Regulation of plasma factor XIII binding to fibrin in vitro. Blood. 1985; 66(5):1028-34. View

20.

Lewis S, Janus T, Lorand L, Shafer J . Regulation of formation of factor XIIIa by its fibrin substrates. Biochemistry. 1985; 24(24):6772-7. DOI: 10.1021/bi00345a007. View